Literature DB >> 19277765

Mood and energy determinants of quality of life in dystonia.

Anne Soeder1, Benzi M Kluger, Michael S Okun, Cynthia W Garvan, Thomas Soeder, Charles E Jacobson, Ramon L Rodriguez, Rick Turner, Hubert H Fernandez.   

Abstract

Prior research has demonstrated that dystonia patients may have reductions in numerous measures of quality of life (QOL) when compared to healthy age-matched controls. However, the determinants of QOL in this patient population have not been fully specified. To address this issue, we administered the Medical Outcomes Study Short Form 36 (SF-36) questionnaire along with the Visual Analogue Mood Scale (VAMS), the Beck Depression Inventory (BDI), the Unified Dystonia Rating Scale (UDRS), and the State and Trait Anxiety Index (STAI) to 73 patients diagnosed with primary dystonia. Dystonia patients demonstrated lower QOL on all subscales of the SF-36 compared to normative healthy age-matched data. While the UDRS, a predominantly motor scale, was not significantly correlated with QOL (r = -0.19, P = 0.11), the BDI (r = -0.79, P < 0.0001), the STAI (r = -0.63, P < 0.0001) and multiple subscales of the VAMS revealed significant correlations. The tired subscale was the item most strongly correlated with overall QOL (r = -0.52, P < 0.0001), and particularly QOL related to physical function. The association of tiredness with QOL remained significant even when adjusting for the BDI and STAI scores (P < 0.0001). This study highlights the importance of mood and energy in QOL among a cohort of patients with dystonia. Further studies will be needed to determine the effect of treatment on these associations and whether disturbances in energy are related to sleep disturbances or to primary fatigue issues.

Entities:  

Mesh:

Year:  2009        PMID: 19277765     DOI: 10.1007/s00415-009-5060-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

Authors:  N Klepac; V Trkulja; M Relja; T Babić
Journal:  Eur J Neurol       Date:  2008-02       Impact factor: 6.089

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Relation between depression and anxiety in dystonic patients: implications for clinical management.

Authors:  E Moraru; P Schnider; A Wimmer; T Wenzel; P Birner; H Griengl; E Auff
Journal:  Depress Anxiety       Date:  2002       Impact factor: 6.505

4.  The prevalence of primary dystonia in the general community.

Authors:  J Müller; S Kiechl; G K Wenning; K Seppi; J Willeit; A Gasperi; J Wissel; T Gasser; W Poewe
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

Review 5.  Fatigue in Parkinson's disease: a review.

Authors:  Joseph H Friedman; Richard G Brown; Cynthia Comella; Carol E Garber; Lauren B Krupp; Jau-Shin Lou; Laura Marsh; Lillian Nail; Lisa Shulman; C Barr Taylor
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

6.  Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life.

Authors:  Amy A Dan; Cathy Crone; Thomas N Wise; Lisa M Martin; Lolita Ramsey; Scarlett Magee; Robert Sjogren; Janus P Ong; Zobair M Younossi
Journal:  Psychosomatics       Date:  2007 May-Jun       Impact factor: 2.386

Review 7.  Poststroke depression: importance of its detection and treatment.

Authors:  Laura Gabaldón; Blanca Fuentes; Ana Frank-García; Exuperio Díez-Tejedor
Journal:  Cerebrovasc Dis       Date:  2007-11-01       Impact factor: 2.762

8.  Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Authors:  Connie Marras; Michael P McDermott; Paula A Rochon; Caroline M Tanner; Gary Naglie; Anthony E Lang
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

9.  Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

Authors:  I M Skogseid; U F Malt; J Røislien; E Kerty
Journal:  Eur J Neurol       Date:  2007-08-15       Impact factor: 6.089

10.  Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin.

Authors:  R Djebbari; S T du Montcel; S Sangla; J S Vidal; G Gallouedec; M Vidailhet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

View more
  10 in total

Review 1.  Nonmotor manifestations of dystonia: a systematic review.

Authors:  Daniel J Kuyper; Veronica Parra; Shanae Aerts; Michael S Okun; Benzi M Kluger
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

Review 2.  The effectiveness of physiotherapy for cervical dystonia: a systematic literature review.

Authors:  Joke De Pauw; Kevin Van der Velden; Jill Meirte; Ulrike Van Daele; Steven Truijen; Patrick Cras; Rudy Mercelis; Willem De Hertogh
Journal:  J Neurol       Date:  2014-01-12       Impact factor: 4.849

Review 3.  The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.

Authors:  Maria Stamelou; Mark J Edwards; Mark Hallett; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

4.  Quality of life in isolated dystonia: non-motor manifestations matter.

Authors:  Johanna Junker; Brian D Berman; James Hall; Deena W Wahba; Valerie Brandt; Joel S Perlmutter; Joseph Jankovic; Irene A Malaty; Aparna Wagle Shukla; Stephen G Reich; Alberto J Espay; Kevin R Duque; Neepa Patel; Emmanuel Roze; Marie Vidailhet; H A Jinnah; Norbert Brüggemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-09       Impact factor: 13.654

5.  A Cross-Cultural Validation of the Filipino and Hiligaynon Versions of the Parts IIIB (Non-Motor Features) and IV (Activities of Daily Living) of the X-Linked Dystonia-Parkinsonism- MDSP Rating Scale.

Authors:  Richelle Ann S Santiano; Raymond L Rosales
Journal:  Clin Park Relat Disord       Date:  2021-06-12

Review 6.  Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia.

Authors:  Damiana Scuteri; Kengo Hamamura; Chizuko Watanabe; Paolo Tonin; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

7.  Fatigue, Sleep Disturbances, and Their Influence on Quality of Life in Cervical Dystonia Patients.

Authors:  Marenka Smit; Arwen S J Kamphuis; Anna L Bartels; Vladimir Han; Roy E Stewart; Inge Zijdewind; Marina A Tijssen
Journal:  Mov Disord Clin Pract       Date:  2016-12-05

Review 8.  The genetics of dystonia: new twists in an old tale.

Authors:  Gavin Charlesworth; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

9.  Psychiatric associations of adult-onset focal dystonia phenotypes.

Authors:  Brian D Berman; Johanna Junker; Erika Shelton; Stefan H Sillau; H A Jinnah; Joel S Perlmutter; Alberto J Espay; Joseph Jankovic; Marie Vidailhet; Cecilia Bonnet; William Ondo; Irene A Malaty; Ramón Rodríguez; William M McDonald; Laura Marsh; Mateusz Zurowski; Tobias Bäumer; Norbert Brüggemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04-24       Impact factor: 10.154

10.  Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia.

Authors:  Lisa Klingelhoefer; Maximilian Kaiser; Anna Sauerbier; Robert Untucht; Miriam Wienecke; Könül Mammadova; Björn Falkenburger; Olaf Gregor; K Ray Chaudhuri; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2020-11-04       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.